Product image of Ondansetrom Medlink (Ondansetron) supplied by GNH India

Ondansetrom Medlink

Active Ingredient:
Ondansetron
Origin:
EU

Ondansetrom Medlink (Ondansetron)

Ondansetron, the active ingredient in Ondansetrom Medlink, is a 5‑HT3 receptor antagonist presented as an injectable formulation for intramuscular and intravenous use. It is used to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients. GNH India supplies Ondansetrom Medlink as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Medlink Pharma Lda.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ondansetron is a selective 5‑HT3 receptor antagonist that reduces nausea and vomiting signals in the chemoreceptor trigger zone and gastrointestinal tract.

  • Chemotherapy‑induced nausea and vomiting: prevents or reduces nausea and vomiting in patients receiving cytotoxic chemotherapy.
  • Postoperative nausea and vomiting: decreases the incidence of nausea and vomiting after surgical procedures.
  • Radiation‑induced nausea and vomiting: mitigates nausea and vomiting caused by therapeutic radiation exposure.

How It Works

  • Ondansetron selectively blocks serotonin 5‑HT3 receptors located on vagal nerve terminals in the gastrointestinal tract and in the chemoreceptor trigger zone of the brain. By antagonizing these receptors, it interrupts the signaling cascade that initiates the vomiting reflex, thereby reducing the perception of nausea and the act of vomiting.

Side Effects

Ondansetron may cause adverse reactions ranging from mild to serious.

Common Side Effects

  • Headache: mild to moderate headache reported.
  • Constipation: reduced bowel movements may occur.
  • Dizziness: transient sensation of light‑headedness.
  • Injection site pain: discomfort at the site of intramuscular or intravenous administration.

Serious or Rare Side Effects

  • Arrhythmia: irregular heart rhythm, including QT prolongation.
  • Severe allergic reaction: anaphylaxis or hypersensitivity requiring immediate medical attention.
  • QT prolongation: potential for life‑threatening cardiac events.

Precautions & Warnings

Before using Ondansetron, consider the following safety measures.

  • Pregnancy: consult the prescriber; limited data are available on fetal safety.
  • Renal impairment: dose adjustment may be required in patients with severe renal dysfunction.
  • Cardiac risk: avoid in patients with known prolonged QT interval or other significant cardiac arrhythmias.
  • Drug interactions: review concomitant medications for potential interactions.
  • Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Ondansetron can interact with several medications; monitoring is essential.

Major Interactions (Avoid)

  • Apomorphine: may cause severe hypotension and loss of consciousness.
  • Other 5‑HT3 antagonists: additive antiemetic effects may increase risk of cardiac events.
  • Serotonergic agents: increased risk of serotonin syndrome.

Moderate Interactions (Monitor Closely)

  • Cisplatin and other chemotherapeutics: may heighten QT‑prolongation risk.
  • Macrolide antibiotics (e.g., erythromycin, azithromycin): may raise plasma levels of ondansetron.
  • Rifampin: may reduce ondansetron effectiveness by increasing metabolism.

Frequently Asked Questions

Ondansetrom Medlink contains ondansetron, a 5‑HT3 receptor antagonist used to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, and postoperative recovery. It is administered by injection to patients who are at risk of these symptoms.

Ondansetron blocks serotonin 5‑HT3 receptors in the chemoreceptor trigger zone of the brain and on vagal afferents in the gastrointestinal tract. By preventing serotonin from activating these receptors, it interrupts the neural pathways that trigger the vomiting reflex.

The specific dose and dosing schedule are determined by the prescribing clinician based on the patient’s condition, age, weight, and the type of emetogenic stimulus. Healthcare professionals tailor the regimen to achieve optimal anti‑emetic control.

Safety data for ondansetron in pregnancy and lactation are limited. The prescriber should evaluate the potential benefits against any possible risks before prescribing to pregnant or nursing patients.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain where required), and import documentation.

Ondansetron is a first‑line 5‑HT3 antagonist offering rapid onset and high efficacy for chemotherapy‑, radiation‑, and postoperative‑induced nausea. Alternatives such as dopamine antagonists or corticosteroids may be used in combination but generally have different side‑effect profiles and mechanisms.

The product should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Follow the manufacturer’s packaging instructions to maintain product stability.

Ondansetrom Medlink is given by intramuscular or intravenous injection. The route, infusion rate, and volume are determined by the healthcare professional based on the clinical situation and patient needs.

Serious risks include cardiac arrhythmias such as QT prolongation, severe allergic reactions (anaphylaxis), and rare cases of serotonin syndrome when combined with serotonergic drugs. Patients should be monitored for these events, especially if they have pre‑existing cardiac conditions.

Patients with known hypersensitivity to ondansetron or any component of the formulation should avoid use. Additionally, individuals with a history of prolonged QT interval or those taking medications that significantly prolong QT should be evaluated carefully before administration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ondansetron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT